Bio Medica Laboratories Ltd
Bio Medica Laboratories Ltd Live Price Chart
Performance
| Previous Close | ₹ 150.05 |
| High | ₹ 157.25 |
| Volume | 78000 |
| 52W Range | ₹ - ₹ |
| Open | ₹ 157.25 |
| Low | ₹ 145 |
| Market Cap | ₹ 174.42 Cr |
Bio Medica Laboratories Ltd Technicals
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
| 20 Day | ₹ 0.000 |
| 50 Day | ₹ 0.000 |
| 100 Day | ₹ 0.000 |
| 200 Day | ₹ 0.000 |
Bio Medica Laboratories Ltd Fundamentals
| ROCE | 35.245 |
| P/E Ratio | 0.000 |
| P/B Ratio | 2.960 |
| Industry P/E | 2.960 |
| Debt to Equity | 50.630 |
| ROE | 44.199 |
| EPS | 0.000 |
| Dividend Yield | 0.000 |
| Book Value | 49.243 |
| Face Value | 10.000 |
Bio Medica Laboratories Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 |
|---|---|---|---|
| Total Revenue | 38.325 | 15.3443 | 16.2496 |
| Total Expenses | 25.1823 | 11.6939 | 15.7975 |
| Profit After Tax | 9.7949 | 2.4987 | 0.3335 |
Bio Medica Laboratories Ltd Shareholding Pattern
| Promoter Holdings | 67.697 % |
| FIIs | 0.286 % |
| DIIs | 2.306 % |
| MutualFund | 0.000 % |
| Retail | 21.384 % |
| Others - | 8.326 % |
About Bio Medica Laboratories Ltd
Bio Medica Laboratories Limited was originally incorporated as a private limited Company with the name of 'Bio Medica Laboratories Private Limited' vide certificate of Incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior. Further, the status got converted into a Public Company & name of the Company changed from 'Bio Medica Laboratories Private Limited' to 'Bio Medica Laboratories Limited' & Registrar of Companies, CPC has issued a new Certificate of Incorporation dated October 24, 2024. Company is engaged in the of manufacturing of Pharmaceutical Parenteral Formulations. It manufacture variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Company operates on a B2B business model through contract manufacturing and does not deal directly with the end users. It manufacture formulations for various companies according to their specific requirements and specifications for the type of formulation needed. Additionally, it enter into agreements with them, allowing their name and address to be displayed on the packaging as 'Technical Collaborator' or 'marketed by' alongside the Company's name as the manufacturer. Company is planning the public issue by issuing an aggregate of 37,71,600 equity shares of face value Rs 10 ...
FAQs on Bio Medica Laboratories Ltd
1. Can I buy Bio Medica Laboratories Ltd from PL Capital? ›
2. Does Bio Medica Laboratories Ltd pay dividends? ›
3. What is the current share price of Bio Medica Laboratories Ltd ? ›
4. What is the 52-week high and low of Bio Medica Laboratories Ltd ? ›
Start SIP in Bio Medica Laboratories Ltd
Invest systematically in stocks with the
PL Capital app
Are you a new user? Open your account
